Moira is a passionate advocate for health care technology reaching patients who need it. Her ‘bench to boardroom’ experience allows her to effectively align clinical, manufacturing, and commercial functions in devising and implementing solutions for cell/gene therapies, advanced oncologics, and other therapies that struggle with fit in healthcare systems.
Her keen eye for opportunities and pitfalls in commercial planning confidently guides clients in a way that resonates across multiple pharma/biopharma business functions. Moira’s solutions stick because she understands it ‘takes a village’ to get therapies to patients.
Prior to joining Blue Fin Group, Dr. Ringo served as a Product Lifecycle Innovation Lead for GlaxoSmithKline, focusing on late-stage and newly launched products in multiple therapeutic areas. She also had 10+ year career as a Research and Development scientist at GlaxoSmithKline that culminated in regulatory approval for four products in the US, EU, and Japan.